Created through the combination of Stallergenes and Greer Laboratories, the company has the largest finished allergy immunotherapy product manufacturing globally, an extensive global footprint and a product portfolio across the immunotherapy value chain.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze